MétaCan
Menu
Back to cohort

Nursing support program to decrease or prevent side effects of pegylated liposomal doxorubicin (PLD) in patients with recurrent epithelial ovarian cancer (REOC)

2005· article· en· W2223063298 on OpenAlexaff
N. Grenier, V. Lebel, M. John Gill, K. Mitchinson, Micah John Foster, Sara Lewis, K. Sebborn, A. Rodgers, Jean‐François Pouliot, Thomas D. Mullen

Bibliographic record

VenueJournal of Clinical Oncology · 2005
Typearticle
Languageen
FieldMedicine
TopicChemotherapy-related skin toxicity
Canadian institutionsHôpital Notre-DameLakeridge Health
Fundersnot available
KeywordsMedicineDiscontinuationTopotecanAdverse effectInternal medicineOvarian cancerChemotherapyCancerOncology

Abstract

fetched live from OpenAlex

8198 Background: A significant long-term survival with PLD compared to topotecan was recently reported in a phase III randomized study of women with REOC (Gyn. Oncol. 2004). PLD is known to be relatively less toxic than topotecan and conventional doxorubicin, however side effects such as palmar-plantar erythrodysesthesia (PPE) may lead to sub-optimal drug exposure and treatment discontinuation. Methods: A nursing support program was created to determine if patient education and proactive nursing care could improve treatment outcomes by decreasing the occurrence and/or severity of PLD-related side effects. Patients who agreed to participate in the program were: educated about potential toxicities associated with PLD, received written instructions on the prevention and management of side effects and were provided with a diary to record symptoms and interventions. Results: A total of 112 ovarian cancer patients who relapsed after one or more prior therapies were accrued in 8 different centers. PLD was administered as 2nd, 3rd and ≥ 4th line therapy in 51%, 34% and 15% of patients, respectively. The majority of patients (85%) received a Taxol/platinum combination as 1st line therapy. The median patient age was 62 years (32–87). The average dose of PLD was 40.4 mg/m2 (35–50) every 28 days for an average of 4.01 cycles (1–23). Efficacy was evaluated using clinical symptoms and/or radiological evaluation. A majority of patients (69%) benefited from therapy characterized as disease stabilization or better. Overall the frequency of adverse events, in these heavily pretreated patients, was similar to that observed in a previous phase III clinical trial (Gordon JCO 2001) where patients had received only one prior therapy. However, the incidence of some grade 3/4 toxicities was substantially decreased, thus grade 3/4 PPE and mucositis were reduced from 21% to 4% and 8% to 3%, respectively. Conclusions: The nursing support program helped to reduce the severity of PPE and mucositis in patients receiving PLD for recurrent epithelial ovarian cancer. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.849
Threshold uncertainty score0.660

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.037
GPT teacher head0.440
Teacher spread0.403 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicChemotherapy-related skin toxicityFrench-language works237,207